Sun Pharma & Moebius Publish Phase 2b Data on MM-I...
Category : Clinical Trial Update 25 April 2025Sun Pharma and Israel-based Moebius Medical Limited announced the publication of two articles in ost...
Clinical Trial Update
Doer Biologics Begins Phase 2 Dosing for DR10624 i...
Category : Clinical Trial Update 25 April 2025Zhejiang Doer Biologics Co., Ltd. (Doer Bio), a clinical stage biopharmaceutical company, announces...
Aclaris Gets FDA Nod to Begin Phase 1a/1b Trial of...
Category : Clinical Trial Update 24 April 2025Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel p...
Zealand Pharma Begins Phase 2b ZUPREME-2 Trial for...
Category : Clinical Trial Update 24 April 2025Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in p...
Bristol Myers’ Camzyos Phase 3 Trial Fails to Meet...
Category : Clinical Trial Update 17 April 2025Bristol Myers Squibb announced the phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the...
Latest Newsletter Post
-
Doer Biologics Begins Phase 2 Dosin..
25 April 2025
-
Augurex’s SPINEstat Approved in UK..
25 April 2025
-
Lupin Gets US FDA Approval for Tolv..
25 April 2025
-
Sun Pharma & Moebius Publish Phase..
25 April 2025
-
Zealand Pharma Begins Phase 2b ZUPR..
24 April 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com